바이오뱅크 시장(2024-2034년)

The global Biobanking market is projected to grow at a CAGR of 9.1% by 2034

The Biobanking Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Investments and Funding Projected to Boost Industry Growth

Biobanks are experiencing increased acknowledgment and support from global governments, research bodies, and financial institutions, leading to a surge in investment in these facilities. Notably, initiatives like the Biorepository and Precision Medicine Initiative Cohort Program, funded by the U.S. National Institutes of Health (NIH), seek to amass biological samples from over a million individuals to establish a comprehensive national research resource. Concurrently, the European Commission has committed funding to the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), a pan-European facility focused on biobanking and biomolecular resources. This heightened attention and financial backing underscore the strategic importance of biobanks in advancing scientific research and precision medicine on a global scale.

Hight Cost of Equipment Likely to Challenge Industry Growth

The market's growth potential is anticipated to face limitations due to the substantial expenses associated with automated equipment. While cutting-edge technologies like advanced sample handling systems have the potential to enhance operational efficiency and elevate the quality of biobanking processes, their high price tags pose a considerable challenge, particularly for smaller biobanking enterprises or those with constrained financial capacities. Take, for instance, the expenditure involved in acquiring an automated storage system, which can vary based on its size and complexity. The initial capital outlay for such systems can be substantial, ranging from tens of thousands to hundreds of thousands of dollars. Beyond the initial investment, ongoing considerations encompass maintenance and operational expenses, including software updates, repairs, and training. This cost factor serves as a strategic consideration for businesses evaluating the incorporation of automated equipment in their biobanking operations.

What Questions Should You Ask before Buying a Market Research Report?

How is the biobanking market evolving?

What is driving and restraining the biobanking market?

How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each biobanking submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the biobanking projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

biobanking projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the biobanking market?

Where is the biobanking market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biobanking market today, and over the next 10 years:

Our 264-page report provides 121 tables and 182 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Ownership

National/Regional Agencies

Universities

Non-profit

Private

Product and Service

Equipment

Consumables

Services

Software

Sample

Blood Products

Human Tissues

Nucleic Acids

Cell Lines

Biological Fluids

Others

Application

Regenerative Medicine

Life Science Research

Clinical Research

End-users

Pharmaceutical & Biotechnology Companies

CROs

Academic & Research Institutes

Hospitals

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

South-East Asia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

ASKION GmbH

Avantor Inc.

Azenta Inc.

Boca Biolistics

BIOIVT & ELEVATING SCIENCE

Cryoport Inc.

CTI Biotech

Hamilton Company

Isenet Biobanking

Merck & Co., Inc.

PHC Holdings Corporation

ProteoGenex Inc.

Qiagen N.V.

Thermo Fisher Scientific, Inc.

Tecan Trading AG

US Biolab Corp. Inc.

Overall world revenue for Biobanking Market, 2024 to 2034 in terms of value the market will surpass US$75.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biobanking Market, 2024 to 2034 report help you?

In summary, our 260+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Biobanking Market 2024 to 2034, with forecasts for ownership, product and service, sample, application, end-users each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Biobanking Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 16 of the major companies involved in the Biobanking Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biobanking Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Biobanking Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report Include:
• 1.6 Who is This Report For?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Increased Focus on Precision Medicine and Genetic Testing
    • 3.2.1.2 Growing Demand for Umbilical Cord Blood Banking
    • 3.2.1.3 Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Private Sponsorship Has Raised a Number of Ethical Issues
    • 3.2.2.2 Issues Related to Biospecimen Sample Procurement
    • 3.2.2.3 Long-term Sustainability of Biobanks
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
    • 3.2.3.2 Opportunities for Cardiovascular Research
    • 3.2.3.3 Growing Focus on the R&D of Cell Therapies
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat of Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Biobanking Market Analysis by Ownership

• 4.1 Key Findings
• 4.2 Ownership Segment: Market Attractiveness Index
• 4.3 Biobanking Market Size Estimation and Forecast by Ownership
• 4.4 National/Regional Agencies
  • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 Universities
  • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 Non-profit
  • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 Private
  • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Biobanking Market Analysis by Sample

• 5.1 Key Findings
• 5.2 Sample Segment: Market Attractiveness Index
• 5.3 Biobanking Market Size Estimation and Forecast by Sample
• 5.4 Blood Products
  • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Human Tissues
  • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 Nucleic Acids
  • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)
• 5.7 Cell Lines
  • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.7.2 Market Share by Region, 2024 & 2034 (%)
• 5.8 Biological Fluids
  • 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.8.2 Market Share by Region, 2024 & 2034 (%)
• 5.9 Others
  • 5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 5.9.2 Market Share by Region, 2024 & 2034 (%)

6 Biobanking Market Analysis by Application

• 6.1 Key Findings
• 6.2 Application Segment: Market Attractiveness Index
• 6.3 Biobanking Market Size Estimation and Forecast by Application
• 6.4 Regenerative Medicine
  • 6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 6.4.2 Market Share by Region, 2024 & 2034 (%)
• 6.5 Life Science Research
  • 6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 6.5.2 Market Share by Region, 2024 & 2034 (%)
• 6.6 Clinical Research
  • 6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 6.6.2 Market Share by Region, 2024 & 2034 (%)

7 Biobanking Market Analysis by Product and Service

• 7.1 Key Findings
• 7.2 Product and Service Segment: Market Attractiveness Index
• 7.3 Biobanking Market Size Estimation and Forecast by Product and Service
• 7.4 Equipment
  • 7.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 7.4.2 Market Share by Region, 2024 & 2034 (%)
• 7.5 Consumables
  • 7.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 7.5.2 Market Share by Region, 2024 & 2034 (%)
• 7.6 Services
  • 7.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 7.6.2 Market Share by Region, 2024 & 2034 (%)
• 7.7 Software
  • 7.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 7.7.2 Market Share by Region, 2024 & 2034 (%)

8 Biobanking Market Analysis by End-users

• 8.1 Key Findings
• 8.2 End-users Segment: Market Attractiveness Index
• 8.3 Biobanking Market Size Estimation and Forecast by End-users
• 8.4 Pharmaceutical & Biotechnology Companies
  • 8.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 8.4.2 Market Share by Region, 2024 & 2034 (%)
• 8.5 CROs
  • 8.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 8.5.2 Market Share by Region, 2024 & 2034 (%)
• 8.6 Academic & Research Institutes
  • 8.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 8.6.2 Market Share by Region, 2024 & 2034 (%)
• 8.7 Hospitals
  • 8.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • 8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Biobanking Market Analysis by Region

• 9.1 Key Findings
• 9.2 Regional Market Size Estimation and Forecast

10 North America Biobanking Market Analysis

• 10.1 Key Findings
• 10.2 North America Biobanking Market Attractiveness Index
• 10.3 North America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 10.4 North America Biobanking Market Size Estimation and Forecast by Country
• 10.5 North America Biobanking Market Size Estimation and Forecast by Ownership
• 10.6 North America Biobanking Market Size Estimation and Forecast by Sample
• 10.7 North America Biobanking Market Size Estimation and Forecast by Application
• 10.8 North America Biobanking Market Size Estimation and Forecast by Product and Service
• 10.9 North America Biobanking Market Size Estimation and Forecast by End-users
• 10.10 U.S. Biobanking Market Analysis
• 10.11 Canada Biobanking Market Analysis

11 Europe Biobanking Market Analysis

• 11.1 Key Findings
• 11.2 Europe Biobanking Market Attractiveness Index
• 11.3 Europe Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 11.4 Europe Biobanking Market Size Estimation and Forecast by Country
• 11.5 Europe Biobanking Market Size Estimation and Forecast by Ownership
• 11.6 Europe Biobanking Market Size Estimation and Forecast by Sample
• 11.7 Europe Biobanking Market Size Estimation and Forecast by Application
• 11.8 Europe Biobanking Market Size Estimation and Forecast by Product and Service
• 11.9 Europe Biobanking Market Size Estimation and Forecast by End-users
• 11.10 Germany Biobanking Market Analysis
• 11.11 UK Biobanking Market Analysis
• 11.12 France Biobanking Market Analysis
• 11.13 Italy Biobanking Market Analysis
• 11.14 Spain Biobanking Market Analysis
• 11.15 Russia Biobanking Market Analysis
• 11.16 Rest of Europe Biobanking Market Analysis

12 Asia Pacific Biobanking Market Analysis

• 12.1 Key Findings
• 12.2 Asia Pacific Biobanking Market Attractiveness Index
• 12.3 Asia Pacific Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 12.4 Asia Pacific Biobanking Market Size Estimation and Forecast by Country
• 12.5 Asia Pacific Biobanking Market Size Estimation and Forecast by Ownership
• 12.6 Asia Pacific Biobanking Market Size Estimation and Forecast by Sample
• 12.7 Asia Pacific Biobanking Market Size Estimation and Forecast by Application
• 12.8 Asia Pacific Biobanking Market Size Estimation and Forecast by Product and Service
• 12.9 Asia Pacific Biobanking Market Size Estimation and Forecast by End-users
• 12.10 Japan Biobanking Market Analysis
• 12.11 China Biobanking Market Analysis
• 12.12 India Biobanking Market Analysis
• 12.13 Australia Biobanking Market Analysis
• 12.14 South Korea Biobanking Market Analysis
• 12.15 South-East Asia Biobanking Market Analysis
• 12.16 Rest of Asia Pacific Biobanking Market Analysis

13 Latin America Biobanking Market Analysis

• 13.1 Key Findings
• 13.2 Latin America Biobanking Market Attractiveness Index
• 13.3 Latin America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 13.4 Latin America Biobanking Market Size Estimation and Forecast by Country
• 13.5 Latin America Biobanking Market Size Estimation and Forecast by Ownership
• 13.6 Latin America Biobanking Market Size Estimation and Forecast by Sample
• 13.7 Latin America Biobanking Market Size Estimation and Forecast by Application
• 13.8 Latin America Biobanking Market Size Estimation and Forecast by Product and Service
• 13.9 Latin America Biobanking Market Size Estimation and Forecast by End-users
• 13.10 Brazil Biobanking Market Analysis
• 13.11 Mexico Biobanking Market Analysis
• 13.12 Rest of Latin America Biobanking Market Analysis

14 MEA Biobanking Market Analysis

• 14.1 Key Findings
• 14.2 MEA Biobanking Market Attractiveness Index
• 14.3 MEA Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 14.4 MEA Biobanking Market Size Estimation and Forecast by Country
• 14.5 MEA Biobanking Market Size Estimation and Forecast by Ownership
• 14.6 MEA Biobanking Market Size Estimation and Forecast by Sample
• 14.7 MEA Biobanking Market Size Estimation and Forecast by Application
• 14.8 MEA Biobanking Market Size Estimation and Forecast by Product and Service
• 14.9 MEA Biobanking Market Size Estimation and Forecast by End-users
• 14.10 GCC Biobanking Market Analysis
• 14.11 South Africa Biobanking Market Analysis
• 14.12 Rest of MEA Biobanking Market Analysis

15 Company Profiles

• 15.1 Thermo Fisher Scientific, Inc.
  • 15.1.1 Company Snapshot
  • 15.1.2 Company Overview
  • 15.1.3 Financial Analysis
    • 15.1.3.1 Net Revenue, 2015-2022
    • 15.1.3.2 Regional Market Shares, 2022
    • 15.1.3.3 R&D, 2015-2022
  • 15.1.4 Product Benchmarking
• 15.2 PHC Holdings Corporation
  • 15.2.1 Company Snapshot
  • 15.2.2 Company Overview
  • 15.2.3 Product Benchmarking
  • 15.2.4 Strategic Outlook
• 15.3 Hamilton Company
  • 15.3.1 Company Snapshot
  • 15.3.2 Company Overview
  • 15.3.3 Product Benchmarking
• 15.4 Avantor Inc.
  • 15.4.1 Company Snapshot
  • 15.4.2 Company Overview
  • 15.4.3 Financial Analysis
    • 15.4.3.1 Net Revenue, 2015-2022
    • 15.4.3.2 Regional Market Shares, 2022
  • 15.4.4 Product Benchmarking
• 15.5 Qiagen N.V.
  • 15.5.1 Company Snapshot
  • 15.5.2 Company Overview
  • 15.5.3 Financial Analysis
    • 15.5.3.1 Net Revenue, 2015-2022
    • 15.5.3.2 Regional Market Shares, 2022
    • 15.5.3.3 R&D, 2015-2022
  • 15.5.4 Product Benchmarking
• 15.6 Tecan Trading AG
  • 15.6.1 Company Snapshot
  • 15.6.2 Company Overview
  • 15.6.3 Product Benchmarking
• 15.7 Merck & Co., Inc.
  • 15.7.1 Company Snapshot
  • 15.7.2 Company Overview
  • 15.7.3 Financial Analysis
    • 15.7.3.1 Net Revenue, 2015-2022
    • 15.7.3.2 Regional Market Shares, 2022
    • 15.7.3.3 R&D, 2015-2022
  • 15.7.4 Product Benchmarking
• 15.8 Cryoport Inc.
  • 15.8.1 Company Snapshot
  • 15.8.2 Company Overview
  • 15.8.3 Financial Analysis
    • 15.8.3.1 Net Revenue, 2015-2022
    • 15.8.3.2 Regional Market Shares, 2022
    • 15.8.3.3 R&D, 2015-2022
  • 15.8.4 Product Benchmarking
  • 15.8.5 Strategic Outlook
• 15.9 Azenta Inc.
  • 15.9.1 Company Snapshot
  • 15.9.2 Company Overview
  • 15.9.3 Financial Analysis
    • 15.9.3.1 Net Revenue, 2015-2022
    • 15.9.3.2 R&D, 2015-2022
  • 15.9.4 Product Benchmarking
• 15.10 Isenet Biobanking
  • 15.10.1 Company Snapshot
  • 15.10.2 Company Overview
  • 15.10.3 Product Benchmarking
• 15.11 CTI Biotech
  • 15.11.1 Company Snapshot
  • 15.11.2 Company Overview
  • 15.11.3 Product Benchmarking
• 15.12 Boca Biolistics
  • 15.12.1 Company Snapshot
  • 15.12.2 Company Overview
  • 15.12.3 Product Benchmarking
  • 15.12.4 Strategic Outlook
• 15.13 BIOIVT & ELEVATING SCIENCE
  • 15.13.1 Company Snapshot
  • 15.13.2 Company Overview
  • 15.13.3 Product Benchmarking
  • 15.13.4 Strategic Outlook
• 15.14 US Biolab Corp. Inc.
  • 15.14.1 Company Snapshot
  • 15.14.2 Company Overview
  • 15.14.3 Product Benchmarking
• 15.15 ProteoGenex Inc.
  • 15.15.1 Company Snapshot
  • 15.15.2 Company Overview
  • 15.15.3 Product Benchmarking
• 15.16 ASKION GmbH
  • 15.16.1 Company Snapshot
  • 15.16.2 Company Overview
  • 15.16.3 Product Benchmarking

16 Conclusion and Recommendations

• 16.1 Concluding Remarks from Visiongain
• 16.2 Recommendations for Market Players